Cart 0
Realising the potential of genomic newborn screening
 
 
 

Transforming fragmented NGS workflows into a streamlined genomics platform

LIMS, automation workflow control, bioinformatics and clinical reporting in a single software solution

 
 

genomic newborn screening

Atlas enables high throughput genomic newborn screening

Compatible with all DNA extraction, library preparation, automation and short read sequencing instruments

 

Works ACROSS any DNA extraction instrument

suitable for any library preparation and automation workflow

integrated secondary analysis, tertiary analysis & reporting

piloted by the Queensland population NBS program

 
 
 
 
 
 

How does atlas enable genomic newborn screening?

Newborn screening requires high throughput, cost-effective testing for treatable conditions

Atlas supports targeted genomics to overcome challenges of whole genome/exome sequencing.

 
 
 

“An automated targeted gene sequencing laboratory workflow and purpose designed bioinformatics pipeline for newborn screening can achieve high throughput testing, a clinically relevant turnaround time, and excellent analytical performance”

Feasibility of targeted next generation DNA sequencing for expanding population newborn screening
Clinical Chemistry, Volume 69, August 2023, Pages 890–900

 
 
navy.jpg
 

Development funded by

 
 
 

How is targeted genomics different?

Types of Genomic Newborn Screening

Targeted Whole Genome/Exome
Genes sequenced Customisable, limited to treatable condtions > 20,000 genes, including untreatable condtions
Genes analysed Limited to treatable conditions Includes actionable conditions, >99% of genes sequenced are ultimately not analysed
Cost Cost effective No published data on cost, higher than targeted
Turnaround time for a batch of 1536 samples 7-10 days No published data on throughput
Uncertainties and incidental/secondary findings Low, due to test being limited to treatable conditions High, requires changes to current NBS consent processes
Analytical performance Sensitivity & specificty > 99% No published data on accuracy
Implementation into NBS Queensland, Australia In research phase
 
light-grey.jpg
 
 
 

We thought it was a no-brainer. Preventive health is the way of the future, why wouldn’t you use the latest technology to screen your children?

Karyn Henner / Read Full Article